
In current hip fracture management, secondary fracture prevention is essential. As part of this process, attention must be given to the prescription of anti-osteoporotic medication (AOM) at discharge. Despite the substantial evidence regarding the consequences of the osteoporosis treatment gap, initiation rates of AOM remain low, and many patients worldwide are still discharged without appropriate therapy.
A recent study evaluated 598 Greek patients with fragility hip fractures (mean age: 82 years) to assess the impact of implementing an in-hospital, surgeon-led AOM algorithm. This was a single-center, population-based study with a low dropout rate.
The study compared three groups:
(1) patients with low-energy hip fractures who were prescribed AOM according to the algorithm between 2020 and 2022, as described in a previously published study [1];
(2) concurrent control patients who refused treatment during the same period, and;
(3) historical control patients hospitalized for hip fragility fractures in the two years prior to the algorithm’s introduction.
Three outcomes were assessed across the groups: AOM initiation rates, 2-year medication persistence, and risk of secondary osteoporotic fracture. Following the introduction of the algorithm, post-fracture AOM initiation increased from 15% to 67%. Medication persistence at 2 years was 56% in the intervention group and 52% in the historical control group. Mortality was significantly higher in both the concurrent control group (27%) and the historical control group (18%) compared with the intervention group (13%).
As highlighted by the findings of both studies about the implementation of the AO Foundation algorithm, its application can substantially increase osteoporosis treatment initiation rates, representing an important step toward improved secondary fracture prevention. Moreover, the algorithm can enhance persistence with AOM and can be implemented without requiring additional healthcare resources.
Reference:
1. Daskalakis II, Kritsotakis EI, Karantanas AH, Kontakis GM, Bastian JD, Tosounidis TH. Application of an in-hospital, surgeon-led anti-osteoporotic medication algorithm in patients with hip fractures improves persistence to medication and can prevent the second fragility fracture. Arch Orthop Trauma Surg. 2024;144:683–92.
© 2026 Global Fragility Fracture Network | All Rights Reserved I Designed by Aaron Knight